Simon Chen
Simon Chen is the Vice President of Bora Pharmaceuticals. His experience in both Pharmaceutical Research and Marketing has established Bora as one of the few companies that can operate with a strong research-driven culture as well as financially focused goals. Prior to joining the Bora Pharmaceutical team, he was the Director of Business Development at Hoan Pharmaceuticals and led successful launches of many new drugs such as Ebixa from Lundbeck, a Danish pharmaceuticals company, and Detantol Retard from Eisai, a Japanese pharmaceuticals company. Simon has also been involved in numerous research teams and key development projects at Medical and Pharmaceutical Industry Technology and Development Center, United Biomedical Inc., and TTY Biopharm.